Omada Health, Inc. OMDA shares ended the last trading session 10.5% higher at $20.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.1% gain over the past four weeks.
Omada Health scored a strong price increase driven by the optimism surrounding its recent presentation at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami. In the first quarter of 2026, the company witnessed its total members crossing 1 million for the first time in since inception, with strong enrollment across the GLP-1 services and across the full suite of cardiometabolic services like hypertension and diabetes.
This company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +155.6%. Revenues are expected to be $80.93 million, up 31.9% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Omada Health, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on OMDA going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Omada Health, Inc. is a member of the Zacks Medical Services industry. One other stock in the same industry, Labcorp Holdings LH, finished the last trading session 1.9% higher at $271.47. LH has returned 1.4% over the past month.
Labcorp's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $4.79. Compared to the company's year-ago EPS, this represents a change of +10.1%. Labcorp currently boasts a Zacks Rank of #2 (Buy).
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Omada Health, Inc. (OMDA): Free Stock Analysis Report
Labcorp Holdings Inc. (LH): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).